BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fouladi DF, Zarghampour M, Pandey P, Pandey A, Varzaneh FN, Ghasabeh MA, Khoshpouri P, Kamel IR. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases. Eur Radiol 2020;30:291-300. [PMID: 31209620 DOI: 10.1007/s00330-019-06289-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Caruso M, Stanzione A, Prinster A, Pizzuti LM, Brunetti A, Maurea S, Mainenti PP. Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases. World J Gastroenterol 2023; 29(3): 521-535 [PMID: 36688023 DOI: 10.3748/wjg.v29.i3.521] [Reference Citation Analysis]
2 Ma X, Ren X, Ma F, Cai S, Ning C, Liu J, Chen X, Zhang G, Qiang J. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer. Gynecol Oncol 2022:S0090-8258(22)00249-9. [PMID: 35469683 DOI: 10.1016/j.ygyno.2022.04.008] [Reference Citation Analysis]
3 Zhu H, Xu D, Zhang X, Li X, Xing B, Sun Y. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy. Ann Surg Oncol. [DOI: 10.1245/s10434-021-11101-y] [Reference Citation Analysis]
4 Liu B, Li C, Sun X, Zhou W, Sun J, Liu H, Li S, Jia H, Xing L, Dong X. Assessment and Prognostic Value of Immediate Changes in Post-Ablation Intratumor Density Heterogeneity of Pulmonary Tumors via Radiomics-Based Computed Tomography Features. Front Oncol 2021;11:615174. [PMID: 34804908 DOI: 10.3389/fonc.2021.615174] [Reference Citation Analysis]
5 Drewes R, Pech M, Powerski M, Omari J, Heinze C, Damm R, Wienke A, Surov A. Apparent Diffusion Coefficient Can Predict Response to Chemotherapy of Liver Metastases in Colorectal Cancer. Acad Radiol 2021;28 Suppl 1:S73-80. [PMID: 33008734 DOI: 10.1016/j.acra.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Uutela A, Ovissi A, Hakkarainen A, Ristimäki A, Lundbom N, Kallio R, Soveri LM, Salminen T, Ålgars A, Halonen P, Ristamäki R, Nordin A, Blanco Sequeiros R, Rinta-Kiikka I, Lantto E, Virtanen J, Pääkkö E, Liukkonen E, Saunavaara J, Ryymin P, Lammentausta E, Osterlund P, Isoniemi H; RAXO Study Group. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial). ESMO Open 2021;6:100208. [PMID: 34325107 DOI: 10.1016/j.esmoop.2021.100208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Yoshikawa M, Morine Y, Yamada S, Miyazaki K, Tokuda K, Saito Y, Arakawa Y, Ikemoto T, Imura S, Shimada M. Prognostic prediction of resectable colorectal liver metastasis using the apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging. Ann Gastroenterol Surg 2021;5:252-8. [PMID: 33860146 DOI: 10.1002/ags3.12404] [Reference Citation Analysis]
8 Vogl TJ, Marko C, Langenbach MC, Naguib NNN, Filmann N, Hammerstingl R, Gruber-Rouh T. Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial. Eur Radiol 2021;31:2242-51. [PMID: 32960329 DOI: 10.1007/s00330-020-07253-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]